Lancet 398(10313):18111824
"The buzz around these drugs has been amplified by viral social media discussions, media coverage, and even celebrity endorsements
Nevertheless, Neeland and his colleagues concluded that the available evidence suggests that the proportion of lean and muscle mass people lose while taking GLP-1s is in line with the proportion that people lose through diet and exercise alone, but called for additional research to confirm
Clin Gastroenterol Hepatol 2024;22:197-199.e3
Eli Lilly's TRIUMPH program includes trials covering obesity, cardiovascular disease, knee osteoarthritis, and long-term cardiovascular outcomes
( D ) Quantification of glucose oxidation measured in caSMCs that were pretreated with 100 nM GLP-1(2836) or scrambled control for 20 minutes